Small fiber polyneuropathy is a well-recognized syndrome mitigated by somatic sensory afferent and autonomic efferent nerve fibers that respectively mediate pain, heat and cold temperature afferent and autonomic efferent function in the skin. A patient with low serum titers of neuronal acetylcholine receptor ganglionic antibodies and autonomic failure had symptomatic small fiber polyneuropathy late in life in the setting of autoimmune dementia and encephalopathy and prostate cancer. Large and small fiber polyneuropathy and dysautonomia were detected in routine electrodiagnostic and autonomic laboratory studies, and epidermal nerve fiber analysis of the calf and thigh. Clinical improvement for one year concomitant with intravenous immune globulin therapy preceded?a?clinical?decline in neurocognitive function and death. Postmortem examination showed typical features of Alzheimer disease with neuropathic neuropathological changes in the peripheral nervous system,?and viable autonomic ganglia consistent with a channelopathy mechanism involving postsynaptic neuronal nAChRs.
References
[1]
Bakkers, M., Faber, C.G., Hoeljmakers, J.G.J., et al. (2014) Small-Fibers, Large Impact: Quality of Life in Small-Fiber Neuropathy. Muscle Nerve, 49, 329-336.
https://doi.org/10.1002/mus.23910
[2]
Novak, V., Freimer, M.L., Kissel, J.T., et al. (2001) Autonomic Impairment in Painful Neuropathy. Neurology, 56, 861-868. https://doi.org/10.1212/WNL.56.7.861
[3]
Sandroni, P. and Low, P.A. (2009) Other Autonomic Neuropathies Associated with Ganglionic Antibody. Autonomic Neuroscience, 146, 13-17.
https://doi.org/10.1016/j.autneu.2008.10.022
[4]
Cutsforth-Gregory, J.K., McKeon, A., Coon, E.A., et al. (2018) Ganglionic Antibody Level as a Predictor of Severity of Autonomic Failure. Mayo Clinic Proceedings, 93, 1440-1447. https://doi.org/10.1016/j.mayocp.2018.05.033
[5]
Nakane, S., Mukaino, A., Higuchi, O., et al. (2018) Autoimmune Autonomic Ganglionopathy: An Update on Diagnosis and Treatment. Expert Review of Neurotherapeutics, 18, 953-965. https://doi.org/10.1080/14737175.2018.1540304
[6]
Vernino, S., Lindstrom, J., Hopkins, S., et al. (2008) Characterization of Ganglionic Acetylcholine Receptor Autoantibodies. Journal of Neuroimmunology, 197, 63-69.
https://doi.org/10.1016/j.jneuroim.2008.03.017
[7]
Vernino, S., Low, P.A. and Lennon, V.A. (2003) Experimental Autoimmune Autonomic Neuropathy. Journal of Neurophysiology, 90, 2053-2059.
https://doi.org/10.1152/jn.00408.2003
[8]
Vernino, S., Low, P.A., Fealey, R.D., et al. (2000) Autoantibodies to Ganglionic Acetylcholine Receptors in Autoimmune Autonomic Neuropathies. The New England Journal of Medicine, 343, 847-855.
https://doi.org/10.1056/NEJM200009213431204
[9]
Gibbons, C.H. and Freeman, F. (2009) Antibody Titers Predict Clinical Features of Autoimmune Autonomic Ganglionopathy. Autonomic Neuroscience: Basic and Clinical, 146, 8-12. https://doi.org/10.1016/j.autneu.2008.11.013
[10]
Baker, S.K., Morillo, C. and Vernino, S. (2009) Autoimmune Autonomic Ganglionopathy with Late-Onset Encephalopathy. Autonomic Neuroscience: Basic and Clinical, 146, 29-32. https://doi.org/10.1016/j.autneu.2008.10.016
[11]
Gibbons, C., Centi, J., Vernino, S., et al. (2012) Autoimmune Autonomic Ganglionopathy with Reversible Cognitive Impairment. Archives of Neurology & Psychiatry, 69, 461-466. https://doi.org/10.1001/archneurol.2011.2372